Oncology Institute, Inc. Operating Income Loss

• Oncology Institute, Inc. showed an increase of +40.0% in Operating Income Loss from 2024 to 2025.
• This data is from Oncology Institute, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), Oncology Institute, Inc.'s Operating Income Loss has declined by 340.2%.
• Historical annual values: Fiscal year 2025: -$36.08 million | Fiscal year 2024: -$60.12 million | Fiscal year 2023: -$77.02 million | Fiscal year 2022: -$81.95 million | Fiscal year 2021: -$45.86 million | Fiscal year 2020: -$8.20 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026